Biodefense - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Biodefense market is accounted for $5.47 billion in 2018 and is expected to reach $8.85 billion by 2027 growing at a CAGR of 5.5% during the forecast period. Some of the key factors propelling the market growth are rising investment by the governments in developed countries and technological advancements. However, less penetration in developing and underdeveloped countries is the restraining factor for the growth of the market.
Biodefense constitutes the use of medical measures, to protect individuals against bioterrorism, including interventions, such as drugs and vaccinations. Furthermore, there is an improvement, in terms of research and public health preparations, in order to defend against biological attacks. There is an increasing awareness regarding synthetic biology, mainly for using biological organisms, to reduce the burden of diseases, especially for improving agricultural yields.
By product, vaccines segment is segregated into anthrax, antibiotics, botulism, E-Bola, eye shield, immunization vaccine, nuclear/radiation, smallpox, and zika. Anthrax segment is expected to grow at the significant market share during the forecast period owing to the increased investment on production and stockpiling of anthrax vaccine by government agencies such as the Centre for Disease Control (CDC) and Department of Defense among others.
On the basis of geography, North America is anticipated to hold considerable market share during the forecast period due to increase spending by the governments across the globe to develop and store sufficient vaccines against anthrax and U.S government implementing the number of initiatives that assist them in reinforcing security against biological threats.
Some of the key players in Biodefense Market include Xoma Corporation, Altimmune Inc, Bavarian Nordic, Cleveland BioLabs, Dynavax Technologies Inc, Dynport Vaccine Company LLC (DVC), Elusys Therapeutics, Emergent BioSolutions Inc, Ichor Medical Systems, Nanotherapeutics, Ology Bioservices, PathSensors Inc and Siga Technologies Inc.
Products Covered:
• Vaccines
• Biothreat detection devices
Sales Channels Covered:
• Direct Sales
• In Direct Sales
Applications Covered:
• Military
• Civilian
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biodefense Market, By Product
5.1 Introduction
5.2 Vaccines
5.2.1 Anthrax
5.2.2 Antibiotics
5.2.3 Botulism
5.2.4 E-Bola
5.2.5 Eye Shield
5.2.6 Immunization Vaccine
5.2.7 Nuclear/Radiation
5.2.8 Smallpox
5.2.9 Zika
5.3 Biothreat detection devices
5.3.1 Assays and Reagents
5.3.2 Detectors/triggering devices
5.3.3 Identifiers
5.3.4 Samplers
6 Global Biodefense Market, By Sales Channel
6.1 Introduction
6.2 Direct Sales
6.3 In Direct Sales
7 Global Biodefense Market, By Application
7.1 Introduction
7.2 Military
7.3 Civilian
8 Global Biodefense Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Xoma Corporation
10.2 Altimmune Inc
10.3 Bavarian Nordic
10.4 Cleveland BioLabs
10.5 Dynavax Technologies Inc
10.6 Dynport Vaccine Company LLC (DVC)
10.7 Elusys Therapeutics
10.8 Emergent BioSolutions Inc
10.9 Ichor Medical Systems
10.10 Nanotherapeutics
10.11 Ology Bioservices
10.12 PathSensors Inc
10.13 Siga Technologies Inc
List of Tables
1 Global Biodefense Market Outlook, By Region (2017-2027) ($MN)
2 Global Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
3 Global Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
4 Global Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
5 Global Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
6 Global Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
7 Global Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
8 Global Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
9 Global Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
10 Global Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
11 Global Biodefense Market Outlook, By Zika (2017-2027) ($MN)
12 Global Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
13 Global Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
14 Global Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
15 Global Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
16 Global Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
17 Global Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
18 Global Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
19 Global Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
20 Global Biodefense Market Outlook, By Application (2017-2027) ($MN)
21 Global Biodefense Market Outlook, By Military (2017-2027) ($MN)
22 Global Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
23 North America Biodefense Market Outlook, By Country (2017-2027) ($MN)
24 North America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
25 North America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
26 North America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
27 North America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
28 North America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
29 North America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
30 North America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
31 North America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
32 North America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
33 North America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
34 North America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
35 North America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
36 North America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
37 North America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
38 North America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
39 North America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
40 North America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
41 North America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
42 North America Biodefense Market Outlook, By Application (2017-2027) ($MN)
43 North America Biodefense Market Outlook, By Military (2017-2027) ($MN)
44 North America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
45 Europe Biodefense Market Outlook, By Country (2017-2027) ($MN)
46 Europe Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
47 Europe Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
48 Europe Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
49 Europe Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
50 Europe Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
51 Europe Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
52 Europe Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
53 Europe Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
54 Europe Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
55 Europe Biodefense Market Outlook, By Zika (2017-2027) ($MN)
56 Europe Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
57 Europe Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
58 Europe Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
59 Europe Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
60 Europe Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
61 Europe Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
62 Europe Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
63 Europe Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
64 Europe Biodefense Market Outlook, By Application (2017-2027) ($MN)
65 Europe Biodefense Market Outlook, By Military (2017-2027) ($MN)
66 Europe Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
67 Asia Pacific Biodefense Market Outlook, By Country (2017-2027) ($MN)
68 Asia Pacific Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
69 Asia Pacific Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
70 Asia Pacific Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
71 Asia Pacific Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
72 Asia Pacific Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
73 Asia Pacific Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
74 Asia Pacific Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
75 Asia Pacific Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
76 Asia Pacific Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
77 Asia Pacific Biodefense Market Outlook, By Zika (2017-2027) ($MN)
78 Asia Pacific Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
79 Asia Pacific Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
80 Asia Pacific Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
81 Asia Pacific Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
82 Asia Pacific Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
83 Asia Pacific Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
84 Asia Pacific Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
85 Asia Pacific Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
86 Asia Pacific Biodefense Market Outlook, By Application (2017-2027) ($MN)
87 Asia Pacific Biodefense Market Outlook, By Military (2017-2027) ($MN)
88 Asia Pacific Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
89 South America Biodefense Market Outlook, By Country (2017-2027) ($MN)
90 South America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
91 South America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
92 South America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
93 South America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
94 South America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
95 South America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
96 South America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
97 South America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
98 South America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
99 South America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
100 South America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
101 South America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
102 South America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
103 South America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
104 South America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
105 South America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
106 South America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
107 South America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
108 South America Biodefense Market Outlook, By Application (2017-2027) ($MN)
109 South America Biodefense Market Outlook, By Military (2017-2027) ($MN)
110 South America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
111 Middle East & Africa Biodefense Market Outlook, By Country (2017-2027) ($MN)
112 Middle East & Africa Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
113 Middle East & Africa Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
114 Middle East & Africa Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
115 Middle East & Africa Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
116 Middle East & Africa Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
117 Middle East & Africa Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
118 Middle East & Africa Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
119 Middle East & Africa Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
120 Middle East & Africa Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
121 Middle East & Africa Biodefense Market Outlook, By Zika (2017-2027) ($MN)
122 Middle East & Africa Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
123 Middle East & Africa Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
124 Middle East & Africa Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
125 Middle East & Africa Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
126 Middle East & Africa Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
127 Middle East & Africa Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
128 Middle East & Africa Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
129 Middle East & Africa Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
130 Middle East & Africa Biodefense Market Outlook, By Application (2017-2027) ($MN)
131 Middle East & Africa Biodefense Market Outlook, By Military (2017-2027) ($MN)
132 Middle East & Africa Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.